Physician profile
Derek K Afflu
NPI 1629430616
$3,610.11
in general payments reported to CMS, 2019-2025
6 companies · $2,267 in 2025
The $2,267 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,343 · 2025: $2,267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,747 · Food and Beverage: $863 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,746.50 |
| Food and Beverage | $862.61 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,597.46 | 2024-2025 | Sapien 3 Ultra Resilia |
| Artivion, INC. | $978.42 | 2025 | Cryovalve Sg Pulmonary Human Heart Valve, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Cardiac Non-Synergraft |
| Medtronic, INC. | $896.41 | 2024 | Corevalve Evolut R |
| Ethicon US, LLC | $88.46 | 2024 | Evarrest, Prolene, Surgicel Nu-Knit |
| Atricure, INC. | $30.21 | 2025 | Atricure Cryoice Cryoablation System (Cryo2) |
| Bayer Healthcare Pharmaceuticals INC. | $19.15 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Afflu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.